AKE 0.00% $9.83 allkem limited

latest broker report

  1. 180 Posts.
    lightbulb Created with Sketch. 57

    Australian Broker Call Report

    TARGET PRICE$10.75

    Buy

    17 Dec 2021

    UBS

    Upon a change of analyst, UBS sets a $10.75 target price and maintains its Buy rating for Allkem (formerly named Orocobre). It's thought the company has the resource inventory and brine/hard rock...

    TARGET PRICE$12.00

    Buy

    15 Dec 2021

    Ord Minnett

    Ord Minnett retains the view that the lithium market will remain in perpetual deficit and expects compound annual demand growth of 24% through to 2030. In light of this, and strong recent...

    TARGET PRICE$12.00

    Buy

    09 Dec 2021

    Citi

    Cit has published its annual commodities 2022 Outlook and says that, after five solid quarters of outperformance, it expects the sector to take a breather, setting up a "more ...

    TARGET PRICE$12.00

    Outperform

    22 Nov 2021

    Macquarie

    Macquarie believes strong capacity growth in the downstream battery market will spur solid demand in lithium. The broker also points out realised spodumene prices have reached a record high of ...


 
watchlist Created with Sketch. Add AKE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.